Cullinan Therapeutics, Inc. (CGEM) 是一家上市公司 属于 医疗保健 板块，经营于 Medical - Pharmaceuticals 行业. 公司总部位于 Cambridge, MA, 美国. 现任CEO为 Nadim Ahmed.
CGEM 拥有 IPO日期为 2021-01-08, 111 名全职员工, 在 NASDAQ Global Select, 市值为 $868.55M.
Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617. The company was founded by Patrick A. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.
